Genelux (GNLX) Amortizatization of Intangibles (2022 - 2026)

Genelux's (GNLX) quarterly Amortizatization of Intangibles came in at $70000.0 in Q1 2026, down 50.0% year-on-year from $140000.0 in Q1 2025, and up 125.81% quarter-over-quarter from $31000.0 in Q3 2025.

Genelux (GNLX) Amortizatization of Intangibles (2022 - 2026) Analysis & Trends

Genelux's Amortizatization of Intangibles history runs 5 years deep, the most recent figure standing at $70000.0 for Q1 2026.

  • On a quarterly basis, Amortizatization of Intangibles fell 50.0% year-over-year to $70000.0 in Q1 2026; TTM through Mar 2026 was $258000.0, a 62.93% decrease from a year earlier, with the FY2023 full-year figure at $62000.0, down 75.97% from the prior year.
  • Amortizatization of Intangibles rose to $70000.0 in Q1 2026 per GNLX's latest filing, from $31000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $649000.0 in Q1 2023 and bottomed at -$587000.0 in Q4 2023.
  • The 5-year median for Amortizatization of Intangibles is $90000.0 (2022), against an average of $90333.3.
  • Biggest YoY gain for Amortizatization of Intangibles was 1224.49% in 2023; the steepest drop was 633.64% in 2023.
  • Year by year, Amortizatization of Intangibles stood at $110000.0 in 2022, then sank by 633.64% to -$587000.0 in 2023, then surged by 142.93% to $252000.0 in 2024, then slumped by 87.7% to $31000.0 in 2025, then jumped by 125.81% to $70000.0 in 2026.
  • Per Business Quant, the three latest GNLX Amortizatization of Intangibles figures stand at $70000.0 (Q1 2026), $31000.0 (Q3 2025), and $17000.0 (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 3.22 Mn
10 Genelux 129.36 Mn 129.36 Mn - 70,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 70,000.00
Mar 31, 2026 70,000.00
Sep 30, 2025 31,000.00
Sep 30, 2025 31,000.00
Jun 30, 2025 17,000.00
Jun 30, 2025 17,000.00
Mar 31, 2025 140,000.00
Mar 31, 2025 140,000.00
Sep 30, 2024 252,000.00
Sep 30, 2024 252,000.00
Jun 30, 2024 153,000.00
Jun 30, 2024 153,000.00
Mar 31, 2024 151,000.00
Mar 31, 2024 151,000.00
Dec 31, 2023 -587,000.00
Dec 31, 2023 -587,000.00
Mar 31, 2023 649,000.00
Mar 31, 2023 649,000.00
Dec 31, 2022 110,000.00
Dec 31, 2022 110,000.00